© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Success as a CEO  in Drug Development
Posted 26th June 2017

Success as a CEO in Drug Development

Under the Business Elite Awards 2017, the exclusive CEO of the Year - Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Success as a CEO in Drug Development
Image

Under the Business Elite Awards 2017, the exclusive CEO of the Year – Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Francesco Sinigaglia is the CEO and co-founder of Anabasis, an Italian biopharmaceutical company developing Nerve Growth Factor (NGF) for severe eye diseases. In 2011, he sold Anabasis to Dompé for approximately 10 million upfront and 160 million in regulatory and commercial milestones. Francesco’s industry expertise lies in the life science, biotechnology and pharmaceutical sectors.

He starts the interview by detailing his role following the acquisition and his undoubted experience as a seasoned professional in the industry, plus his reflections on his greatest professional achievement to date.

“After the acquisition, I remained on board as COO to complete the development of the NGF. It was a great success, indeed NGF is now being approved in the EU by European Medicines Agency (EMA).

“Going back a bit, I spent more than 35 years in the biotech and pharmaceutical industry. This included 20 years at Roche, with the first 10 of these at the company’s headquarters in Basel and then as a research director in Italy. In 2002, I founded my first biotech company, Bioxell, that I took public on the Swiss Stock Exchange in 2006 and sold it to Cosmo Pharmaceutical three years later. In 2009, I founded the company Anabasis.

“My biggest achievement is the success of Anabasis, both in terms of scientific and clinical development and for the ability to create value. We financed the development programmes by ourselves and through the collaboration agreement with Dompé, thus avoiding the financial support of venture capital and consequently value dilution.”

Francesco then offers his thoughts on what makes him stand out from other CEO’s and the advice he would you give to anyone wishing to pursue the same career route.

“Drug development is a difficult and risky business. Indeed, only a very few drugs are approved each year and these are mostly from large multinational organisations. To have been able, with rather limited resources, to complete the preclinical, clinical and regulatory development and obtain approval by the regulatory authorities is indeed for me a very major achievement.

“For anybody wishing to take the same career route as me, I would underline that, if you believe that you have a good business idea, just go for it don’t be afraid to fail. It is very true to say that failure is a very important component of the learning process.”

Finally, Francesco draws our attention to another accolade he has won over the past 12 months, including the Best Biopharmaceutical Company – Italy and Excellence Award for Industrial Research 2017, as well as the Business Elite Awards 2017 CEO of the Year – Italy award that this feature interview celebrates.

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Enhancing Legal Compliance: The Role of YouTube Converters in Content Regulation
News
01/07/2024Enhancing Legal Compliance: The Role of YouTube Converters in Content Regulation

The rapid growth of online media and content-sharing platforms like YouTube has revolutionized how content is created, distributed, and consumed. Alongside these advancements, YouTube converters allow users to download and convert videos into different formats

Read Full PostRead - Eye Icon
How to Include Sustainability Initiatives in Email Signatures to Improve Customer Conversion
Corporate Social Responsibility
21/08/2024How to Include Sustainability Initiatives in Email Signatures to Improve Customer Conversion

A recent report highlighted that 63% of consumers are more likely to purchase products from companies that prioritize and highlight their sustainability initiatives. With 7 in 10 customers influenced by a businesses green credentials, it's important that brand

Read Full PostRead - Eye Icon
Arctic Cat Acquires Motorfist
M&A
08/04/2015Arctic Cat Acquires Motorfist

Arctic Cat Acquires Motorfist

Read Full PostRead - Eye Icon
4 Essential Winter Health Hacks
News
21/01/20224 Essential Winter Health Hacks

Christmas has gone, and the January blues have well and truly set in. It’s cold, dark and miserable outside – let’s be honest, you’re feeling a little deflated. The winter can be difficult, between Seasonal Affective Disorder and freezing conditions. I

Read Full PostRead - Eye Icon
Successful Consumer Analytics Equals Successful Digital Marketing
News
27/03/2023Successful Consumer Analytics Equals Successful Digital Marketing

It’s an exciting time to be a marketer, but it’s also a challenging time in the industry. Knowing what mediums to focus on and where to spend your marketing budget is no simple task.

Read Full PostRead - Eye Icon
Cryptography in 2016
Innovation
30/06/2016Cryptography in 2016

Kingston Technology was founded in 1987 and has grown to be the world’s largest independent manufacturer of memory products.

Read Full PostRead - Eye Icon
Tangiers Group Acquires Osprey
Finance
08/04/2015Tangiers Group Acquires Osprey

Tangiers Group Acquires Osprey

Read Full PostRead - Eye Icon
Retail Mapping: Utilizing Contextual Intelligence to Meet Consumers Where They Are
News
27/06/2022Retail Mapping: Utilizing Contextual Intelligence to Meet Consumers Where They Are

Although online shopping has increased by 300%, 56% of shoppers still visit a physical store before making a purchase, and 30% of direct-to-consumer brands say opening a store is a current priority.

Read Full PostRead - Eye Icon
The Benefits of Pushing Branded Content
Finance
27/08/2015The Benefits of Pushing Branded Content

The sudden growth and acceleration of content marketing has enabled small businesses with limited budgets and resources to distinguish themselves in the marketplace by delivering relevant and engaging content to their target audiences.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow